Mentz, R. J., Bethel, M. A., Thompson, V. P., Lokhnygina, Y., Buse, J. B., Chan, J. C., … Hernandez, A. F. (2017). Effect of Exenatide Once-Weekly on Clinical Outcomes in Patients With Type 2 Diabetes Mellitus and Cardiovascular Disease: Insights From the EXSCEL Trial. In CIRCULATION (Vol. 136, pp. E455–E455). Anaheim, CA: LIPPINCOTT WILLIAMS & WILKINS.

Mentz, Robert J., M Angelyn Bethel, Vivian P. Thompson, Yuliya Lokhnygina, John B. Buse, Julian C. Chan, Jasmine Choi, et al. “Effect of Exenatide Once-Weekly on Clinical Outcomes in Patients With Type 2 Diabetes Mellitus and Cardiovascular Disease: Insights From the EXSCEL Trial.” In CIRCULATION, 136:E455–E455. LIPPINCOTT WILLIAMS & WILKINS, 2017.

Mentz RJ, Bethel MA, Thompson VP, Lokhnygina Y, Buse JB, Chan JC, et al. Effect of Exenatide Once-Weekly on Clinical Outcomes in Patients With Type 2 Diabetes Mellitus and Cardiovascular Disease: Insights From the EXSCEL Trial. In: CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2017. p. E455–E455.

Mentz, Robert J., et al. “Effect of Exenatide Once-Weekly on Clinical Outcomes in Patients With Type 2 Diabetes Mellitus and Cardiovascular Disease: Insights From the EXSCEL Trial.” CIRCULATION, vol. 136, no. 24, LIPPINCOTT WILLIAMS & WILKINS, 2017, pp. E455–E455.

Mentz RJ, Bethel MA, Thompson VP, Lokhnygina Y, Buse JB, Chan JC, Choi J, Gustavson SM, Iqbal N, Maggioni AP, Marso SP, Ohman P, Pagidipati NJ, Poulter N, Ramachandran A, Zinman B, Holman RR, Hernandez AF. Effect of Exenatide Once-Weekly on Clinical Outcomes in Patients With Type 2 Diabetes Mellitus and Cardiovascular Disease: Insights From the EXSCEL Trial. CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2017. p. E455–E455.